BR9713924A - inas - Google Patents

inas

Info

Publication number
BR9713924A
BR9713924A BR9713924A BR9713924A BR9713924A BR 9713924 A BR9713924 A BR 9713924A BR 9713924 A BR9713924 A BR 9713924A BR 9713924 A BR9713924 A BR 9713924A BR 9713924 A BR9713924 A BR 9713924A
Authority
BR
Brazil
Prior art keywords
heteroaryl
formula
preparation
compounds
phenylalanines
Prior art date
Application number
BR9713924A
Other languages
English (en)
Other versions
BR9713924B1 (pt
Inventor
Marco Villa
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of BR9713924A publication Critical patent/BR9713924A/pt
Publication of BR9713924B1 publication Critical patent/BR9713924B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)

Abstract

ocesso para a preparação de heteroarila-fenilalaninas e, mais particularmente, refere-se a um processo de acoplamento cruzado para a preparação de derivados de fenilalanina no qual o grupo de fenila é substituído por um grupo de heteroarila.
BRPI9713924-6A 1996-12-24 1997-12-15 processo para a preparaÇço de heteroarilafenilalaninas. BR9713924B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI002738A IT1289522B1 (it) 1996-12-24 1996-12-24 Processo per la preparazione di eteroaril-fenilalanine
PCT/EP1997/007024 WO1998028284A1 (en) 1996-12-24 1997-12-15 Process for the preparation of heteroaryl-phenylalanines

Publications (2)

Publication Number Publication Date
BR9713924A true BR9713924A (pt) 2000-03-21
BR9713924B1 BR9713924B1 (pt) 2009-01-13

Family

ID=11375489

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9713924-6A BR9713924B1 (pt) 1996-12-24 1997-12-15 processo para a preparaÇço de heteroarilafenilalaninas.

Country Status (15)

Country Link
US (1) US6448408B1 (pt)
EP (1) EP0948492B1 (pt)
JP (1) JP4226659B2 (pt)
AT (1) ATE203017T1 (pt)
BR (1) BR9713924B1 (pt)
CA (1) CA2275764C (pt)
CZ (1) CZ296240B6 (pt)
DE (1) DE69705640T2 (pt)
DK (1) DK0948492T3 (pt)
ES (1) ES2159892T3 (pt)
GR (1) GR3036855T3 (pt)
IL (1) IL130364A (pt)
IT (1) IT1289522B1 (pt)
PT (1) PT948492E (pt)
WO (1) WO1998028284A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1454898A4 (en) * 2001-12-13 2006-12-13 Ajinomoto Kk NEW PHENYL ALANIDE DERIVATIVES
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277737B1 (it) 1995-12-28 1997-11-12 Zambon Spa Derivati tiolici ad attivita' inibitrice delle metallopeptidasi

Also Published As

Publication number Publication date
IT1289522B1 (it) 1998-10-15
DE69705640T2 (de) 2002-05-02
EP0948492B1 (en) 2001-07-11
ATE203017T1 (de) 2001-07-15
US20020028946A1 (en) 2002-03-07
ITMI962738A1 (it) 1998-06-24
CZ230799A3 (cs) 1999-12-15
CA2275764C (en) 2007-09-18
JP2001506662A (ja) 2001-05-22
DK0948492T3 (da) 2001-10-15
IL130364A0 (en) 2000-06-01
CZ296240B6 (cs) 2006-02-15
DE69705640D1 (de) 2001-08-16
JP4226659B2 (ja) 2009-02-18
CA2275764A1 (en) 1998-07-02
EP0948492A1 (en) 1999-10-13
GR3036855T3 (en) 2002-01-31
WO1998028284A1 (en) 1998-07-02
ES2159892T3 (es) 2001-10-16
PT948492E (pt) 2001-11-30
US6448408B1 (en) 2002-09-10
BR9713924B1 (pt) 2009-01-13
IL130364A (en) 2003-07-06

Similar Documents

Publication Publication Date Title
CY1111236T1 (el) Ανοσοτροποποιητικες ενωσεις που περιεχουν γαμμα-γλουταμυλο και βητα-ασπαρτυλο τμημα και μεθοδοι με αυτες
DK0870768T3 (da) Azaindol-ethylaminderivater som nikotinacetylcholinreceptor-bindingsmidler
ES8206474A1 (es) Un procedimiento para la obtencion de un derivado acilado sustituido de acido octahidro-1h-indol-2-carboxilico
ES8802153A1 (es) Procedimiento para preparar derivados de isoxazol y furano.
DK0887344T3 (da) Quinoliner og quinazoliner, som er nyttige ved terapi
DK1113011T3 (da) Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
ES2189941T3 (es) Derivados de nucleosidos aciclicos.
ES551987A0 (es) Procedimiento para preparar derivados de cefalosporina.
KR900003156A (ko) 진통제 화합물, 그의 제조방법 및 그를 함유하는 약학 조성물
DK160098C (da) Tricycliske oxindolcarboxamid-derivater
ES2061966T3 (es) Mejoras introducidas en la sintesis de derivados 6-metilenicos de androsta-1,4-dieno-3,17-diona.
PT90572A (pt) Processo para a preparacao de derivados de 6-fenil-3-piperazinilalquil-1h,3h-2,4-pirimidinadiona
MX170732B (es) Composicion de derivados de succinimida y su uso
BR9713924A (pt) inas
SE8203877L (sv) Aminosulfonylbensoesyraderivat
ATE140229T1 (de) Benzoxazepinon-verfahren
PT83816B (pt) Processo para a preparacao de derivados de cefalosporina
EA199800720A1 (ru) Гетероциклические производные эрголина в качестве лигандов 5-htia рецептора
DK369289D0 (da) Anvendelse af imidazopyrazolderivater som analgetica og antiinflammatoriske midler
AU4507989A (en) Aryloxy-, arylthio-, heteroaryloxy-, heteroarylthio- alkenylene derivatives of amines
TH13791EX (th) อนุพันธ์ต่างๆของกรดบิวไทริค

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 25/02/2009, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.